2023, Number 1
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2023; 21 (1)
Paradoxical exacerbation of acne associated with isotretinoin
González GMF, Cortés PEC
Language: Spanish
References: 14
Page: 40-44
PDF size: 169.17 Kb.
ABSTRACT
Isotretinoin is considered the only acne drug capable of changing
the natural course of the disease. However, outbreaks, or
flare up, of acneiform lesions have been described after drug
administration; patients can present a paradoxical exacerbation
of acne, particularly of the inflammatory component. The risk
factors identified are: initiation of treatment with high doses
of isotretinoin, the presence of macrocomedones or multiple
closed microcomedones, and types of acne with an underlying
inflammatory component. There are preventive and alternative
therapies for the treatment of acne flare ups, the latter used
when remission of the disease is not achieved with isotretinoin.
We present two cases with paradoxical acne outbreak associated
to isotretinoin and, its consequent remission with antiinflammatory
therapy.
REFERENCES
Zaenglein A, Pathy A, Schlosser B, Alikhan A, Baldwin H, Berson D etal., Guidelines of care for the management of acne vulgaris, AmericanAcademy of Dermatology 2016; 74:945-73.
Rigopoulos D, Larios G y Katsambas A, The role of isotretinoin in acnetherapy: why not as first line therapy? facts and controversies, Clinicsin Dermatology 2010; 28:24-30.
Arenas R, Acné vulgar. En Dermatología. Atlas, diagnóstico y tratamiento,México, McGraw Hill, 2019, pp. 27-38.
Blasiak R, Stamey C, Burkhart C, Lugo-Somolinos A y Morrell D, Highdoseisotretinoin treatment and the rate of retrial, relapse, and adverseeffects in patients with acne vulgaris, jama Dermatology 2013;149:1392-98.
Wise E y Graber E, Clinical pearl: comedone extraction for persistentmacrocomedones while on isotretinoin therapy, The Journal of Clinicaland Aesthetic Dermatology 2011; 4:20-1.
Borghi A, Mantovani L, Minghetti S, Virgili A y Bettoli V, Acute acneflare following isotretinoin administration: potential protective role oflow starting dose, Dermatology 2008; 178-80.
Liu J, Shi L, Zhang L, Liu X, Zhang H, Zhang Y et al., Acute acne flarefollowing isotretinoin administration successfully treated by 5-aminolevulinicacid photodynamic therapy, Photodiagnosis and PhotodynamicTherapy 2022; 1-3.
Rosa L, Gerin O y Ferreira F, Pseudo-acne fulminans associated withoral isotretinoin, Anais Brasileiros de Dermatologia 2014; 89:657-9.
De Kanwar A, Combination of low-dose isotretinoin and pulsed oralazithromycin in the management of moderate to severe acne, ClinicalDrug Investigation 2011; 31:599-604.
Lee H, Chang I, Lee Y, Kim C, Seo Y, Lee J et al., Effect of antihistamineas an adjuvant treatment of isotretinoin in acne: a randomized, controlledcomparative study, Journal of the European Academy of Dermatologyand Venereology 2014; 1-7.
Pei S, Inamadar A, Adya K y Tsoukas M, Light-based therapies in acnetreatment, Indian Dermatology Online Journal 2015; 6:145-57.
Goldberg D y Russell B, Combination blue (415 nm) and red (633 nm)led phototherapy in the treatment of mild to severe acne vulgaris,Journal of Cosmetic and Laser Therapy 2006; 8:71-5.
Al-Kathiri R y Al-Najjar T, Severe nodulocystic acne not respondingto isotretinoin therapy successfully treated with oral dapsone, OmanMedical Journal 2018; 5:433-6.
Pinto C, García-Huidobro I y Hasson A, Terapia fotodinámica conmetil aminolevulinato y ácido 5-aminolevulínico en acné inflamatorioleve y moderado: experiencia clínica, Revista Chilena de Dermatología2010; 26:25-9.